Matches in Wikidata for { <http://www.wikidata.org/entity/Q80397545> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q80397545 description "article scientifique publié en 2007" @default.
- Q80397545 description "artículu científicu espublizáu n'agostu de 2007" @default.
- Q80397545 description "scientific article published on 01 August 2007" @default.
- Q80397545 description "wetenschappelijk artikel" @default.
- Q80397545 description "наукова стаття, опублікована в серпні 2007" @default.
- Q80397545 name "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 name "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 type Item @default.
- Q80397545 label "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 label "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 prefLabel "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 prefLabel "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 P1433 Q80397545-5E9199D2-C4DA-4D0E-95AF-D62F121702B6 @default.
- Q80397545 P1476 Q80397545-B5B44A23-13A5-48FE-944C-B8CE7816D87E @default.
- Q80397545 P304 Q80397545-6590AC84-EDD1-4279-BA47-49B7BA3DF143 @default.
- Q80397545 P31 Q80397545-614EC1A0-0E9D-4FDC-B418-FF4F31063499 @default.
- Q80397545 P356 Q80397545-B7B0FF9D-839C-48BE-87F7-D7E528CC754F @default.
- Q80397545 P433 Q80397545-76E049C4-2471-4556-B78F-60C3F0C8AA6E @default.
- Q80397545 P478 Q80397545-A80D1FE3-FD01-4062-9F79-D4A98571EA09 @default.
- Q80397545 P50 Q80397545-44B60730-7C26-45D9-987B-3C8A496401B5 @default.
- Q80397545 P50 Q80397545-6DAB8300-E2B5-4733-BFBC-663AF14FED34 @default.
- Q80397545 P50 Q80397545-7F137DF5-C32F-42FD-8DA8-B1C493E57ADB @default.
- Q80397545 P577 Q80397545-4333C37E-2076-459B-9EDA-0BB9E20586E1 @default.
- Q80397545 P698 Q80397545-9F3FB6DF-4283-4DDB-A457-8EBCF226E3FA @default.
- Q80397545 P921 Q80397545-8A887939-FF46-4CED-AECC-AAA90F21B1C4 @default.
- Q80397545 P921 Q80397545-9768CA92-810C-4C58-ABA8-70F1EE9E9A6F @default.
- Q80397545 P921 Q80397545-A88041EB-098E-4BED-AF60-B1EE37F3A22B @default.
- Q80397545 P356 MDS.21579 @default.
- Q80397545 P698 17534964 @default.
- Q80397545 P1433 Q1486418 @default.
- Q80397545 P1476 "Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure" @default.
- Q80397545 P304 "1678-1679" @default.
- Q80397545 P31 Q13442814 @default.
- Q80397545 P356 "10.1002/MDS.21579" @default.
- Q80397545 P433 "11" @default.
- Q80397545 P478 "22" @default.
- Q80397545 P50 Q104434024 @default.
- Q80397545 P50 Q88593434 @default.
- Q80397545 P50 Q90055228 @default.
- Q80397545 P577 "2007-08-01T00:00:00Z" @default.
- Q80397545 P698 "17534964" @default.
- Q80397545 P921 Q11085 @default.
- Q80397545 P921 Q181754 @default.
- Q80397545 P921 Q19000661 @default.